development of a new compound containing both molecules, aimed as an improved treatment of ulcerative colitis. The present case investigated the capacity of the two active agents to interact
infl ammatory conditions of the gastrointestinal tract and comprise Crohn’s disease (CD) and ulcerative colitis (UC). Both CD and UC are characterized by a great extent of heterogeneity
Inflammatory bowel diseases (IBD), including Crohn\\\\\\\\\\\\\\'s disease and ulcerative colitis, are chronic inflammatory diseases with a significant increase in cases in recent years. The exact etiology of IBD remains
established treatment in inflammatory bowel disease (IBD) namely Crohn’s disease (CD) and ulcerative colitis (UC). However, this treatment is associated with high costs and the possibility of severe adverse
Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) characterized by chronic and relapsing inflammation of the gastro-intestinal tract (GIT). They cause lifelong suffering
Colonic diseases like ulcerative colitis, Crohn's disease, and colon cancer are on rise due to variations in the dietary and lifestyle habits. Increase in prevalence of such diseases
frequently in patients with inflammatory bowel disease, especially Crohn’s disease and rarely in ulcerative colitis. Isolated involvement of scrotal region is quite rare without concomitant inflammatory bowel disease…
European guidelines recommend a relatively strict surveillance policy. This surveillance strategy is applied to ulcerative colitis but also to Crohn's disease: initial surveillance colonoscopy should be performed in each
presentation: We describe a 59 year-old man with a 20 year history of ulcerative colitis treated with azathioprine during 6 years who developed a primary central nervous system Hodgkin
Objective: 5-Amino salicylicacid (5-ASA) is the cornerstone of ulcerative colitis treatment, with (assessment of) non-adherence as a challenge. Multi-matrix release (MMX)-mesalazine has the advantage
anti-smooth muscle (ASM) antibodies. AIH-1 is associated with immunological illnesses such as ulcerative colitis, sclerosing cholangitis, arthritis, and vasculitis. AIH-2 is more frequent in children. It presents
Pharmacotherapy rediscovered the management of ulcerative colitis and Crohn’s disease. Novel drug delivery systems are popular in treating IBD. The treatment of IBD with novel drug delivery system
gene expression during the course of IBD have shown increased vimentin, expression especially in ulcerative colitis. In addition, interaction between vimentin and nucleotide binding oligomerization domain-containing…
restorative proctocolectomy (RPC) and ileal pouch-anal anastomosis (IPAA)? for surgical treatment of ulcerative colitis (UC) and familial adenomatous polyposis (FAP). RPC replaces the colon and rectum by a pouch
Such alterations may contribute to many chronic and degenerative diseases (e.g., Crohn?s disease, ulcerative colitis, rheumatoid arthritis, irritable bowel syndrome, inflammatory bowel disease, and other ?intestinal…
treat the various disease of colon such as Crohn’s disease and ulcerative colitis. The azo adduct did not release drug in acidic environment of stomach, but when
associated with inflammatory bowel disease. We describe here a 42-year-old woman with ulcerative colitis who manifested verrucous and pyogenic lesions on her scalp, neck, axillae, inguinal areas, umbilicus
Caucasians (TT plus Tt versus tt: OR = 0.79, 95%CI = 0.63- 1.00), and with ulcerative colitis (UC) risk (T versus t: OR = 0.89, 95%CI = 0.80-0.99). There
colon), such as Colon cancer, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) i.e. Ulcerative colitis and Crohn’s disease, Diverticulitis and other colon diseases, where it is necessary
chronic inflammatory disorder of the bowel represented by two major forms; Ulcerative colitis (UC) and Crohn’s disease (CD). The idiopathic nature of this disease manifests due to irregular intestinal
appears to have a good diagnostic precision in predicting IBD relapse, possibly more in ulcerative colitis than in Crohn’s disease. However, mainly for this last topic, available evidences, although
Crohn’s disease (CD) and ulcerative colitis (UC), the two major forms of inflammatory bowel disease (IBD) in human beings, the pathological process is driven by an excessive immune response
Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are featured by chronic intestinal inflammation, which is becoming increasingly prevalent in Western societies, and is spreading
ICAM-1) with Inflammatory Bowel Disease (IBD), including Crohn’s Disease (CD) and Ulcerative Colitis (UC), in different populations. However, the results of these individual studies have been inconsistent. Therefore
effective dose). Probiotic therapy can be utilized to prevent several diseases like ulcerative colitis, Traveler?s diarrhea, Crohn?s disease, etc. Thus, quantification of genes encoding specific physiological attributes
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.